Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
PIMAVANSERIN | A214782 | AUROBINDO PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al 3 patentsANDA 214782pimavanserin tartrate | D. Del. | 2022-10-21 | Active | — |
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al 4 patentsANDA 214782pimavanserin tartrate | D. Del. | 2020-07-24 | Terminated 2024-05-07 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.